NCT06524570 2026-02-18
iFOCUS
UMC Utrecht
Phase 1 Recruiting
Clinical Trials
7 trialsNCT07142200 2025-08-26
DECIDING
RenJi Hospital
Phase 2 Not yet recruiting
NCT06076135 2025-06-15
ILDR-01
Shantou University Medical College
Phase 2 Active not recruiting
NCT06047860 2023-09-21
A Clinical Study of Recombinant Human Vascular Endothelial Inhibitor in Combination With PRaG for Advanced Refractory Non-small Cell Lung Cancer
Second Affiliated Hospital of Soochow University
Phase 2 Unknown
NCT03790488 2023-07-03
Study of a PD-1 Inhibitor (JTX-4014) in Subjects With Solid Tumor Malignancies
Jounce Therapeutics, Inc.
Phase 1 Completed
NCT05790447 2023-03-30
Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors
Second Affiliated Hospital of Soochow University
Phase 2 Unknown
NCT05530200 2022-09-07
PRaG Regimens Rechallenge for Patients With Resistance to PD1/PD-L1 Inhibitors in Refractory Advanced Solid Tumors.
Second Affiliated Hospital of Soochow University
Phase 2 Unknown